These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7926148)

  • 1. Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization.
    Hull MG; Armatage RJ; McDermott A
    Fertil Steril; 1994 Nov; 62(5):997-1003. PubMed ID: 7926148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation.
    Bagratee JS; Lockwood G; López Bernal A; Barlow DH; Ledger WL
    J Assist Reprod Genet; 1998 Feb; 15(2):65-9. PubMed ID: 9513843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
    Usui A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro fertilisation for unexplained subfertility.
    Pandian Z; Bhattacharya S; Nikolaou D; Vale L; Templeton A
    Cochrane Database Syst Rev; 2002; (2):CD003357. PubMed ID: 12076476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience using preparations of follicle-stimulating hormone alone to stimulate the ovaries for assisted conception after pituitary desensitisation and simplified management of treatment.
    Hull MG; Joels LA; Prosser CJ; Ashcroft SA
    Horm Res; 1995; 43(5):230-7. PubMed ID: 7782056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of in vitro fertilization and embryo transfer in women with infertility due to genital tuberculosis.
    Gurgan T; Urman B; Yarali H
    Fertil Steril; 1996 Feb; 65(2):367-70. PubMed ID: 8566264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro fertilisation and gamete intrafallopian transfer: an integrative analysis of research, 1987-1992.
    Kenny DT
    Br J Obstet Gynaecol; 1995 Apr; 102(4):317-25. PubMed ID: 7612516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer.
    Pal L; Shifren JL; Isaacson KB; Chang Y; Leykin L; Toth TL
    J Assist Reprod Genet; 1998 Jan; 15(1):27-31. PubMed ID: 9493063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
    Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
    Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF; Estes MA
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
    Van Wely M; Westergaard LG; Bossuyt PM; Van der Veen F
    Cochrane Database Syst Rev; 2003; (1):CD003973. PubMed ID: 12535497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
    Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
    Daya S
    Cochrane Database Syst Rev; 2007 Jul; (1):CD001299. PubMed ID: 17636664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection.
    Takeuchi S; Minoura H; Shibahara T; Tsuiki Y; Noritaka F; Toyoda N
    Fertil Steril; 2001 Sep; 76(3):532-7. PubMed ID: 11532477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro fertilization, gamete intrafallopian transfer and combined IVF-GIFT results: three-year experience at Chang Gung Memorial Hospital.
    Soong YK; Chang MY; Chang SY; Chang SD; Chen MH; Jou DS; Wang ML
    Taiwan Yi Xue Hui Za Zhi; 1989 Oct; 88(10):1023-31. PubMed ID: 2699491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.